Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Propofol and Alfentanil

PreclinicalSmall molecule

FFirst Affiliated Hospital of Zhejiang University

1

Indications

2

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q4 2026

Post-ApprovalRecruiting

Bronchoscopy

NCT07395596

Clinical

Trials by Indication[1]

Sedation1 trial

Comparison Between Nurse-Administered Propofol Sedation and Diazemuls / Pethidine in Outpatient Colonoscopy

Completed·NNorth District Hospital·N/A·NCT00566683·194 enrolled

Bronchoscopy1 trial

Remimazolam for Bronchoscopy in High-Risk Patients

Recruiting·FFirst Affiliated Hospital of Zhejiang University·Phase 4·NCT07395596·360 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Propofol and Alfentanil. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Propofol and Alfentanil compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Propofol and Alfentanil. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — First Affiliated Hospital of Zhejiang University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: FFirst Affiliated Hospital of Zhejiang University

Related News